SE8009068L - Partiklar av lipoidlosliga substanser, blandningar innefattande sadana partiklar och pa dessa adsorberade biologiskt aktiva substanser liksom even sett for framstellning av sadana blandningar - Google Patents

Partiklar av lipoidlosliga substanser, blandningar innefattande sadana partiklar och pa dessa adsorberade biologiskt aktiva substanser liksom even sett for framstellning av sadana blandningar

Info

Publication number
SE8009068L
SE8009068L SE8009068A SE8009068A SE8009068L SE 8009068 L SE8009068 L SE 8009068L SE 8009068 A SE8009068 A SE 8009068A SE 8009068 A SE8009068 A SE 8009068A SE 8009068 L SE8009068 L SE 8009068L
Authority
SE
Sweden
Prior art keywords
particles
mixtures
biologically active
substances
seen
Prior art date
Application number
SE8009068A
Other languages
Unknown language ( )
English (en)
Other versions
SE453537B (sv
Inventor
Z Riedl
L Sztankov
I Horvath
Original Assignee
Human Oltoanyagtermelo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Human Oltoanyagtermelo filed Critical Human Oltoanyagtermelo
Publication of SE8009068L publication Critical patent/SE8009068L/sv
Publication of SE453537B publication Critical patent/SE453537B/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1271—Non-conventional liposomes, e.g. PEGylated liposomes, liposomes coated with polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/531—Production of immunochemical test materials
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Public Health (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SE8009068A 1979-12-27 1980-12-22 Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser SE453537B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU79HU299A HU184141B (en) 1979-12-27 1979-12-27 Adjuvant particles compositions containing said particles and biologically active substances adsorbed thereon and a process for the preparation thereof

Publications (2)

Publication Number Publication Date
SE8009068L true SE8009068L (sv) 1981-06-28
SE453537B SE453537B (sv) 1988-02-08

Family

ID=10997378

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8009068A SE453537B (sv) 1979-12-27 1980-12-22 Sett att framstella blandningar innehallande partiklar av lipoidlosliga substanser och vid dessa bundna biologiskt aktiva substanser

Country Status (21)

Country Link
US (1) US4396630A (sv)
JP (1) JPS57112334A (sv)
BE (1) BE886884A (sv)
CA (1) CA1165237A (sv)
CH (1) CH655246A5 (sv)
CS (1) CS241478B2 (sv)
DD (1) DD158738A5 (sv)
DE (1) DE3048815A1 (sv)
DK (1) DK160288C (sv)
ES (1) ES498048A0 (sv)
FR (1) FR2472386B1 (sv)
GB (1) GB2066203B (sv)
HU (1) HU184141B (sv)
IT (1) IT1150073B (sv)
NL (1) NL8007041A (sv)
PL (1) PL228755A1 (sv)
PT (1) PT72261B (sv)
RO (1) RO81371A (sv)
SE (1) SE453537B (sv)
SU (1) SU1487802A3 (sv)
YU (1) YU44413B (sv)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4598051A (en) * 1980-03-12 1986-07-01 The Regents Of The University Of California Liposome conjugates and diagnostic methods therewith
US4806466A (en) * 1981-10-29 1989-02-21 The Regents Of The University Of California Cell agglutination reagent comprising conjugates of antibody covalently bound to liposomes
FR2521565B1 (fr) * 1982-02-17 1985-07-05 Dior Sa Parfums Christian Melange pulverulent de constituants lipidiques et de constituants hydrophobes, procede pour le preparer, phases lamellaires lipidiques hydratees et procede de fabrication, compositions pharmaceutiques ou cosmetiques comportant des phases lamellaires lipidiques hydratees
DD247570A3 (de) * 1983-01-14 1987-07-15 Univ Berlin Humboldt Vesikulaeres trenn-, fuell- und traegermaterial
US4515736A (en) * 1983-05-12 1985-05-07 The Regents Of The University Of California Method for encapsulating materials into liposomes
US5059591B1 (en) * 1983-05-26 2000-04-25 Liposome Co Inc Drug preparations of reduced toxicity
US4708861A (en) * 1984-02-15 1987-11-24 The Liposome Company, Inc. Liposome-gel compositions
US5916588A (en) * 1984-04-12 1999-06-29 The Liposome Company, Inc. Peptide-containing liposomes, immunogenic liposomes and methods of preparation and use
US6090406A (en) * 1984-04-12 2000-07-18 The Liposome Company, Inc. Potentiation of immune responses with liposomal adjuvants
GB2160312B (en) * 1984-04-13 1987-09-16 South African Inventions Adjuvant for immunisation
PT78628B (en) * 1984-05-02 1986-06-18 Liposome Co Inc Pharmaceutical composition with reduced toxicity
US4619904A (en) * 1984-10-29 1986-10-28 General Electric Company Agglutinating immunoassay using protein-coated liquid droplets
US4857319A (en) * 1985-01-11 1989-08-15 The Regents Of The University Of California Method for preserving liposomes
ATE68686T1 (de) * 1985-10-31 1991-11-15 Kv Pharm Co System zum freigeben von stoffen in der vagina.
US5266329A (en) * 1985-10-31 1993-11-30 Kv Pharmaceutical Company Vaginal delivery system
US4790987A (en) * 1985-11-15 1988-12-13 Research Corporation Viral glycoprotein subunit vaccine
CA1338736C (fr) * 1986-12-05 1996-11-26 Roger Baurain Microcristaux comportant une substance active presentant une affinite pour les phospholipides, et au moins un phospholipide, procede de preparation
US5688519A (en) * 1987-04-06 1997-11-18 Leonard; Robert J. Flash-flow fused medicinal implants
US4748024A (en) * 1987-04-06 1988-05-31 Endocon, Inc. Flash flow fused medicinal implants
WO1990001948A1 (en) * 1988-08-25 1990-03-08 The Liposome Company, Inc. Influenza vaccine and novel adjuvants
ATE118096T1 (de) * 1988-12-22 1995-02-15 Baxter Diagnostics Inc Lipohaptene und verwendung trägergebundener lipohaptene im immuntest.
US5100662A (en) * 1989-08-23 1992-03-31 The Liposome Company, Inc. Steroidal liposomes exhibiting enhanced stability
JPH07113641B2 (ja) * 1989-11-17 1995-12-06 積水化学工業株式会社 梅毒診断試薬の製造方法
NL9000207A (sv) * 1990-01-29 1991-08-16 Duphar Int Res
US5709879A (en) * 1990-06-29 1998-01-20 Chiron Corporation Vaccine compositions containing liposomes
DE69131709T2 (de) * 1990-06-29 2000-05-25 Chiron Corp., Emeryville Liposomen enthaltende impfstoffzusammensetzungen
IE912535A1 (en) * 1990-07-27 1992-01-29 Res Dev Foundation Liposomes that Provide Thymic Dependent Help to Weak Vaccine¹Antigens
WO1992004887A1 (en) * 1990-09-25 1992-04-02 Kyowa Hakko Kogyo Co., Ltd. Induction of cytotoxic t cell
US6048531A (en) * 1991-04-15 2000-04-11 Albany Medical College Immunogenic composites capable of stimulating production of anti-peptide antibodies, pharmaceutical compositions employing these composites and methods of selectively inducing production of anti-peptide antibodies
US5336507A (en) * 1992-12-11 1994-08-09 Sterling Winthrop Inc. Use of charged phospholipids to reduce nanoparticle aggregation
GB9320668D0 (en) * 1993-10-07 1993-11-24 Secr Defence Liposomes containing particulare materials
AUPM500494A0 (en) * 1994-04-12 1994-05-05 Minister For Agriculture & Rural Affairs For The State Of New South Wales, The Composition for use in increasing mucosal immunity
BR0115260A (pt) * 2000-11-09 2005-08-16 Neopharm Inc Complexos de sn-38 com lipìdeos e seus usos no tratamento de doenças
WO2003030864A1 (en) * 2001-05-29 2003-04-17 Neopharm, Inc. Liposomal formulation of irinotecan
AU2003230600B2 (en) * 2002-03-05 2009-06-04 Transave, Inc. An inhalation system for prevention and treatment of intracellular infections
US20060030578A1 (en) * 2002-08-20 2006-02-09 Neopharm, Inc. Pharmaceutically active lipid based formulation of irinotecan
WO2004035032A2 (en) * 2002-08-20 2004-04-29 Neopharm, Inc. Pharmaceutical formulations of camptothecine derivatives
US7879351B2 (en) * 2002-10-29 2011-02-01 Transave, Inc. High delivery rates for lipid based drug formulations, and methods of treatment thereof
CN1747738B (zh) * 2002-10-29 2010-11-24 川塞夫有限公司 缓释抗感染剂
US7718189B2 (en) 2002-10-29 2010-05-18 Transave, Inc. Sustained release of antiinfectives
KR100651728B1 (ko) * 2004-11-10 2006-12-06 한국전자통신연구원 정착기를 갖는 전자 소자용 화합물 및 이를 포함하는 전자소자와 이들의 제조 방법
JP5114628B2 (ja) * 2005-02-25 2013-01-09 国立大学法人三重大学 リポソームワクチンの作製法
HUE029994T2 (en) 2005-12-08 2017-04-28 Insmed Inc Lipid-based preparations of antinfectants for the treatment of lung infections
US20100196455A1 (en) 2007-05-04 2010-08-05 Transave, Inc. Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
US9333214B2 (en) 2007-05-07 2016-05-10 Insmed Incorporated Method for treating pulmonary disorders with liposomal amikacin formulations
US9119783B2 (en) 2007-05-07 2015-09-01 Insmed Incorporated Method of treating pulmonary disorders with liposomal amikacin formulations
US9114081B2 (en) 2007-05-07 2015-08-25 Insmed Incorporated Methods of treating pulmonary disorders with liposomal amikacin formulations
US20150272880A1 (en) 2012-05-21 2015-10-01 Insmed Incorporated Systems for treating pulmonary infections
BR112015012351A8 (pt) 2012-11-29 2019-10-01 Insmed Inc composição de antibiótico de glicopeptídeo à base de lipídeo estabilizado e uso de um componente lipídico, um componente de antibiótico de glicopeptídeo e um aminoácido ou derivado do mesmo
PL3142643T3 (pl) 2014-05-15 2019-12-31 Insmed Incorporated Sposoby leczenia zakażeń płuc prątkami niegruźliczymi
JP7460534B2 (ja) 2018-03-30 2024-04-02 インスメッド インコーポレイテッド リポソーム医薬品の連続製造方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3265629A (en) * 1958-12-22 1966-08-09 Ncr Co Coating by phase separation
DE2249552A1 (de) * 1971-10-12 1973-05-30 Inchema S A Verfahren zur inkapsulation von insbesondere wasserloeslichen verbindungen
GB1502774A (en) * 1974-06-25 1978-03-01 Nat Res Dev Immunological preparations
JPS5126213A (ja) * 1974-08-21 1976-03-04 Tanabe Seiyaku Co Johoseibiryushiseizaino seiho
GB1564500A (en) * 1975-09-29 1980-04-10 Wellcome Found Biological preparations
GB1523965A (en) * 1976-03-19 1978-09-06 Ici Ltd Pharmaceutical compositions containing steroids
GB1575343A (en) * 1977-05-10 1980-09-17 Ici Ltd Method for preparing liposome compositions containing biologically active compounds
IT1110989B (it) * 1979-01-19 1986-01-13 Erba Farmitalia Forme farmaceutiche costitutite da liposomi e procedimenti relativi
FR2416008A1 (fr) * 1978-02-02 1979-08-31 Oreal Lyophilisats de liposomes
US4235871A (en) * 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
JPS55118415A (en) * 1979-02-28 1980-09-11 Pii Papahadojiyopo Dometoriosu Method of encapsulating biologically active substance in lipoid cell

Also Published As

Publication number Publication date
PT72261B (en) 1981-11-05
RO81371B (ro) 1983-11-02
FR2472386B1 (sv) 1985-08-23
CS241478B2 (en) 1986-03-13
GB2066203B (en) 1984-01-11
CS924680A2 (en) 1985-07-16
DK552280A (da) 1981-06-28
PT72261A (en) 1981-01-01
SE453537B (sv) 1988-02-08
CA1165237A (en) 1984-04-10
DK160288C (da) 1991-08-05
SU1487802A3 (ru) 1989-06-15
HU184141B (en) 1984-07-30
RO81371A (ro) 1984-04-02
IT1150073B (it) 1986-12-10
JPS57112334A (en) 1982-07-13
GB2066203A (en) 1981-07-08
DK160288B (da) 1991-02-25
YU44413B (en) 1990-08-31
IT8026950A0 (it) 1980-12-24
US4396630A (en) 1983-08-02
BE886884A (fr) 1981-06-29
CH655246A5 (de) 1986-04-15
DE3048815A1 (de) 1981-09-10
PL228755A1 (sv) 1982-02-15
ES8201316A1 (es) 1981-12-16
YU329080A (en) 1984-04-30
FR2472386A1 (sv) 1981-07-03
ES498048A0 (es) 1981-12-16
DD158738A5 (de) 1983-02-02
NL8007041A (nl) 1981-07-16
JPH0314814B2 (sv) 1991-02-27

Similar Documents

Publication Publication Date Title
SE8009068L (sv) Partiklar av lipoidlosliga substanser, blandningar innefattande sadana partiklar och pa dessa adsorberade biologiskt aktiva substanser liksom even sett for framstellning av sadana blandningar
AU8050791A (en) Compositions and methods for the controlled release of soluble active substances
IL89503A0 (en) Taxol derivatives,pharmaceutical compositions containing the same and process for the preparation thereof
PH21386A (en) Platinum-diamine complexes, their pharmaceutical compositions and process for the preparation thereof
GR3004448T3 (sv)
CY1250A (en) N-heterocyclyl-4-piperdinamines,methods for their preparation and pharmaceutical compositions comprising them
DE3366494D1 (de) New 6-substituted-s-triazolo(3,4-a)phthalazine derivatives
GB2065122B (en) Basic ethers their preparation and pharmaceutical compositions containing the same
EP0105924A4 (en) DRY POWDER WITH IMPROVED FLOW AND COMPRESSION BEHAVIOR AND METHOD FOR PRODUCING THE COMPOSITION.
MX9102500A (es) Compuestos de bifenilio, procedimiento para su preparacion y composicion farmaceutica que los contiene.
AU7929391A (en) New 1,2,3,4,5,6-hexahydroazepino(4,5-b)indoles and 1,2,3,4-tetrahydro-beta-carbolines processes for preparing these and pharmaceutical compositions containing them
ES2157886T3 (es) Composiciones tensioactivas y procedimientos.
IL96326A0 (en) Polymyxin conjugates,their preparation and pharmaceutical compositions containing them
GR3021511T3 (en) Stable freeze dried polyhematoporphyrin ether/ester composition
IL64344A (en) Substituted alkanolamine derivatives,their preparation and pharmaceutical compositions comprising the same
DE69108392D1 (de) Zusammensetzung zur aktivierung der makrophagen.
NO178838C (no) Anvendelse av hydroksyblandingsetere som hjelpemiddel for törking av faststoffer
AU4934485A (en) Solid drug formulations and stable suspensions
FI942222A (sv) Förfarande för framställning av torrbehandlade partiklar, så erhållna torrbehandlade partiklar och farmaceutiska kompositioner innehållande dessa
GB2050833B (en) Pharmaceutical compositions and process for the preparation thereof
AU536582B2 (en) Plenylpiperazine derivatives of 1,3,4-oxiadiazolylphends
AU5852580A (en) 3,4,5-trihydroxypiperidine compounds
GR65642B (en) Method for the preparation of cytostatic preparations which have released from toxicity
EG20082A (en) Process for preparing of octadecyl-(2-N-methylpiperidino)-ethyl-phosphate
IL97509A0 (en) Lipid lowering compositions comprising bambuterol

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8009068-1

Effective date: 19920704

Format of ref document f/p: F